Ongoing outbreaks, including the 2026 Bundibugyo Ebola epidemic declared a public health emergency of international concern in May, have not triggered pandemic-level transmission. Official assessments from the WHO and ECDC emphasize the virus's reliance on direct bodily fluid contact rather than efficient airborne or sustained person-to-person spread, resulting in very low global risk despite rapid local growth in the DRC. Similar dynamics limit Andes hantavirus and other recent zoonotic events. Post-COVID surveillance improvements and the absence of novel high-transmissibility strains support the 82% market-implied odds for no new pandemic before 2028, though traders monitor model updates and case thresholds for any escalation in the remaining timeframe.